• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,531.61 -27.72
(-0.32%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
360.7264827
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
25.8
120075.94
EPS(TTM)
Face Value()
Div & Yield %
57.63
2
0.87
 

&hra pradesh state financial corpn ltd
Triochem Products Ltd - Board Meeting Outcome for Outcome Of The Independent DirectorS Meeting - Pursuant To Regulation 25(3) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015
Mar 21,2025
In pursuance to Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and terms of the provision of Section 173 and Schedule IV of the Companies Act 2013 a separate meeting of the Independent Directors of the company was held today Friday 21st March 2025 at 3.00 p.m. at the registered office of the company at 4th Floor Sambava Chambers Sir P. M. Road Fort Mumbai: 400001 wherein the following items in agenda were considered and discussed: 1) Review the performance of Non-Independent Directors and the Board as a whole. 2) Review the performance of the Chairperson of the company. 3) Assessed the Quality Quantity and timeliness of the flow of information between the company management and the Board that is necessary for the Boad to perform their duties effectively and reasonably.